Next-generation point-of-care diagnostics company
| Date | Round | Amount |
|---|---|---|
| Dec 2022 | Grant London point-of-care diagnostics firm LumiraDx received $14.2M in grants from the Bill & Melinda Gates Foundation to develop a molecular tuberculosis test. | $14.2M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.